Internship
Posted on 7/31/2024
Develops brain-computer interfaces for medical use
$35/hr
Fremont, CA, USA
Neuralink develops brain-computer interfaces (BCIs) that enable direct communication between the brain and external devices. Their main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices through their brain activity. The N1 Implant operates using a wirelessly charged battery and advanced chips that process neural signals, which are then sent to a dedicated application that translates these signals into commands. What sets Neuralink apart from competitors is its focus on both medical applications for individuals with mobility issues and the potential for cognitive enhancement for a broader audience. The company's goal is to restore autonomy to those with medical needs while also exploring the possibilities of human-computer interaction.
Company Size
501-1,000
Company Stage
Series E
Total Funding
$1.3B
Headquarters
Fremont, California
Founded
2016
Help us improve and share your feedback! Did you find this helpful?
An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.
Growth potential. We rapidly advance team members who have an outsized impact.
Excellent medical, dental, and vision insurance through a PPO plan; parental leave.
Flexible time off + paid holidays.
Equity + 401(k) plan.
Commuter Benefits.
Meals provided.
Neuralink, Elon Musk's neurotechnology company, raised $650 million in a Series E funding round. The funds will expand patient access, develop new brain implant devices, and enhance clinical trials. Neuralink's technology, tested in patients with severe paralysis, allows control of devices via thoughts. The FDA granted "breakthrough" status for its speech restoration device. Investors include ARK Invest, Sequoia Capital, and others. Neuralink's pre-funding valuation was approximately $9 billion.
Neuralink Corp., led by CEO Jared Birchall, has raised $649 million in an equity sale, as revealed in an SEC filing. The sale took place on May 30, 2025, with a minimum investment of $12,019 required from outside investors. The company did not disclose its revenue range.
Neuralink, Elon Musk's brain tech startup, said it has closed a $650 million funding round led by ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and others.
Neuralink, led by Elon Musk, raised $650 million in a Series E funding round, with participation from at least 11 investment firms, including Ark Investment Management and Sequoia Capital. The company plans to use the funds to expand patient access and develop next-generation devices that enhance the connection between biological intelligence and AI. Neuralink is valued at $9 billion. Since the last funding round in August 2023, five patients with severe paralysis have used its devices.
Neuralink, founded by Elon Musk in 2016, announced on June 2 that it raised $650 million in a Series E funding round. Investors included ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital. The company is conducting clinical trials, including implanting brain chips in five severely paralyzed patients, and has started trials at major neurosurgical institutions. The funding will expand clinical trials and accelerate innovation in future devices connecting biology and AI.